Selective hydroxamic acid based MMP-12 and MMP-13 inhibitors

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

Shultz, Michael,Tommasi, Ruben Alberto,Weiler, Sven,McQuire, Leslie Wighton,Rogel, Olivier

申请号：

AU2009272807

公开号：

AU2009272807B2

申请日:

2009.07.13

申请国别(地区):

AU

年份:

2012

代理人:

摘要：

The present invention provides a compound of formula (I) said compound is inhibitor of MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by abnormal activity of MMP-12 and/or MMP- 13. Accordingly, the compound of formula (I) can be used in treatment of disorders or diseases mediated by MMP-12 and/or MMP-13. Finally, the present invention also provides pharmaceutical composition that include the compound of formula (I).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/